Tag: Coherus Biosciences Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Coherus Biosciences Inc.

Coherus BioSciences, Inc. (NASDAQ:CHRS) Given Average Rating of "Hold" by Brokerages

Added to Collection on: 2020-12-01 10:43:18

Tags for this article:

Financial markets
Finance
Financial economics
Stock market
Equity securities
Corporate finance
Financial regulation
Short
Stock
Price?earnings ratio
Share
NASDAQ
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Coherus BioSciences, Inc. (NASDAQ:CHRS) CFO Jean-Frederic Viret Sells 46144 Shares

Added to Collection on: 2021-01-27 23:26:15

Tags for this article:

Financial markets
Stock market
Finance
Financial economics
Equity securities
Financial ratios
Corporate finance
Shareholders
Dividend
Stock
Share
Price?earnings ratio
Coherus Biosciences Inc.
S&P 500 INDEX - CBOE
DOW JONES INDUSTRIAL AVERAGE INDEX

Click the tags to see associated articles and topics

View Article Details
Coherus BioSciences to expand late-stage pipeline to immuno-oncology with in-license of Junshi ...

Added to Collection on: 2021-02-01 10:30:00

Tags for this article:

Drugs
Life Sciences
Health care
Biotechnology
Specialty drugs
Monoclonal antibodies
Orphan drugs
Cancer immunotherapy
Genentech
Biosimilar
Adalimumab
Bevacizumab
Coherus Biosciences Inc.
Shanghai Junshi Biosciences
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences and Coherus BioSciences Announce Collaboration to Co-Develop Anti-PD-1 ...

Added to Collection on: 2021-02-01 12:45:00

Tags for this article:

Drugs
Clinical medicine
Cancer treatments
Orphan drugs
Breakthrough therapy
Lung cancer
Angiogenesis inhibitors
Cancer immunotherapy
Melanoma
Non-small-cell lung carcinoma
Head and neck cancer
Bevacizumab
Shanghai
Coherus Biosciences Inc.
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Coherus Deal Signals Pivot to New and Crowded Market

Added to Collection on: 2021-02-08 21:56:15

Tags for this article:

Companies
Life Sciences
Health sciences
Adalimumab
Immunosuppressants
Sanofi
AbbVie
Biosimilar
Bristol-Myers Squibb
Pfizer
Amgen
Merck & Co.
BioGenerics Inc.
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for ...

Added to Collection on: 2021-03-03 17:03:45

Tags for this article:

Drugs
Clinical medicine
Health care
Orphan drugs
Monoclonal antibodies
Breakthrough therapy
Bevacizumab
Bamlanivimab/etesevimab
Cancer immunotherapy
Nasopharyngeal carcinoma
Nivolumab
Pembrolizumab
Shanghai
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
Junshi Biosciences
United States
Canada
China

Click the tags to see associated articles and topics

View Article Details
Coherus and Junshi Biosciences Announce FDA Approval of LOQTORZI™ (toripalimab-tpzi ...

Added to Collection on: 2023-10-28 16:14:08

Tags for this article:

Antineoplastic drugs
Orphan drugs
Breakthrough therapy
Cancer treatments
Cancer immunotherapy
TIGIT
Checkpoint inhibitor
Chemotherapy
Enteropathy-associated T-cell lymphoma
Treatment of lung cancer
Durvalumab
Shanghai
Gemcitabine
shanghai junshi biosciences co., ltd.
Coherus Biosciences Inc.
United States
China
Cisplatin
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
STATEMENT RE COHERUS BIOSCIENCES, INC. | Company Announcement - Investegate

Added to Collection on: 2024-05-10 14:12:56

Tags for this article:

Pharmakon Advisors LP
BioPharma Credit PLC
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Latham Watkins Advises Coherus in Term Loan and Royalty Financing Agreement With Barings

Added to Collection on: 2024-05-13 20:05:28

Tags for this article:

Brassica
Mizuna
Barings LLC
Coherus Biosciences Inc.

Click the tags to see associated articles and topics

View Article Details
Intas Pharmaceuticals, Accord BioPharma acquires UDENYCA - IndiaMedToday

Added to Collection on: 2025-08-08 18:31:11

Tags for this article:

Recombinant proteins
Pegfilgrastim
Intas Pharmaceuticals
Biosimilar
Filgrastim
Accord
Neulasta
Coherus Biosciences Inc.
United States

Click the tags to see associated articles and topics

View Article Details
Book a Demo